Merck KGaA, Darmstadt, Germany

NCT04551950

CollaboratorPhase 1Completed202025 people16 Sept 2020clinicaltrials.gov

NCT04459715

CollaboratorPhase 3Terminated2020730 people7 Jul 2020clinicaltrials.gov

NCT04066491

CollaboratorPhase 2/3Terminated2019309 people26 Aug 2019clinicaltrials.gov

NCT03840902

CollaboratorPhase 2Terminated2019153 people15 Feb 2019clinicaltrials.gov

NCT03717155

Phase 2Completed201843 people24 Oct 2018clinicaltrials.gov

NCT03583385

Phase 1Completed201848 people11 Jul 2018clinicaltrials.gov

NCT03566810

Phase 1Completed201854 people25 Jun 2018clinicaltrials.gov

NCT03467971

Phase 1Completed201821 people16 Mar 2018clinicaltrials.gov

NCT03467945

Phase 1Completed201840 people16 Mar 2018clinicaltrials.gov

NCT03393208

Phase 1Completed201844 people8 Jan 2018clinicaltrials.gov

NCT03116971

CollaboratorPhase 1Terminated20172 people17 Apr 2017clinicaltrials.gov

NCT02576574

CollaboratorPhase 3Completed20151,214 people15 Oct 2015clinicaltrials.gov

NCT02516813

CollaboratorPhase 1Completed201552 people6 Aug 2015clinicaltrials.gov

NCT02383966

Phase 3Completed2015243 people10 Mar 2015clinicaltrials.gov

NCT02255110

Phase 2Terminated20146 people2 Oct 2014clinicaltrials.gov

NCT02252965

Phase 4Completed2014532 people30 Sept 2014clinicaltrials.gov

NCT02157792

CollaboratorPhase 1Completed2012200 people6 Jun 2014clinicaltrials.gov

NCT01514370

Phase 2Completed201280 people23 Jan 2012clinicaltrials.gov

NCT01510522

Phase 4Withdrawn20120 people16 Jan 2012clinicaltrials.gov

NCT01388790

Phase 2Completed201140 people7 Jul 2011clinicaltrials.gov